387 related articles for article (PubMed ID: 29741240)
1. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret.
Zenouzi R; Liwinski T; Yamamura J; Weiler-Normann C; Sebode M; Keller S; Lohse AW; Schramm C;
Aliment Pharmacol Ther; 2018 Jul; 48(2):169-178. PubMed ID: 29741240
[TBL] [Abstract][Full Text] [Related]
2. Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis.
Grigoriadis A; Morsbach F; Voulgarakis N; Said K; Bergquist A; Kartalis N
Scand J Gastroenterol; 2020 Feb; 55(2):228-235. PubMed ID: 32024405
[No Abstract] [Full Text] [Related]
3. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
4. Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography.
Vitellas KM; Keogan MT; Freed KS; Enns RA; Spritzer CE; Baillie JM; Nelson RC
Radiographics; 2000; 20(4):959-75; quiz 1108-9, 1112. PubMed ID: 10903686
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
[TBL] [Abstract][Full Text] [Related]
6. The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis.
Meagher S; Yusoff I; Kennedy W; Martel M; Adam V; Barkun A
Endoscopy; 2007 Mar; 39(3):222-8. PubMed ID: 17385107
[TBL] [Abstract][Full Text] [Related]
7. The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.
Tenca A; Mustonen H; Lind K; Lantto E; Kolho KL; Boyd S; Arola J; Jokelainen K; Färkkilä M
Liver Int; 2018 Dec; 38(12):2329-2339. PubMed ID: 29901259
[TBL] [Abstract][Full Text] [Related]
8. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
[TBL] [Abstract][Full Text] [Related]
9. MR and MRCP in the evaluation of primary sclerosing cholangitis: current applications and imaging findings.
Elsayes KM; Oliveira EP; Narra VR; Abou El Abbass HA; Ahmed MI; Tongdee R; Brown JJ
J Comput Assist Tomogr; 2006; 30(3):398-404. PubMed ID: 16778613
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis.
Kozaka K; Sheedy SP; Eaton JE; Venkatesh SK; Heiken JP
Abdom Radiol (NY); 2020 Aug; 45(8):2388-2399. PubMed ID: 32417935
[TBL] [Abstract][Full Text] [Related]
11. The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review.
Segal D; Marotta P; Mosli M; Zou G; Feagan BG; Al-Judaibi B
Saudi J Gastroenterol; 2019; 25(3):152-158. PubMed ID: 31044745
[TBL] [Abstract][Full Text] [Related]
12. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
Linder S; Söderlund C
Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315
[TBL] [Abstract][Full Text] [Related]
14. Adult bile duct strictures: role of MR imaging and MR cholangiopancreatography in characterization.
Katabathina VS; Dasyam AK; Dasyam N; Hosseinzadeh K
Radiographics; 2014; 34(3):565-86. PubMed ID: 24819781
[TBL] [Abstract][Full Text] [Related]
15. MRCP versus ERCP in the diagnosis of primary sclerosing cholangitis.
Thomson A
Gastrointest Endosc; 2007 Mar; 65(3):558; author reply 558. PubMed ID: 17321274
[No Abstract] [Full Text] [Related]
16. Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography.
Textor HJ; Flacke S; Pauleit D; Keller E; Neubrand M; Terjung B; Gieseke J; Scheurlen C; Sauerbruch T; Schild HH
Endoscopy; 2002 Dec; 34(12):984-90. PubMed ID: 12471543
[TBL] [Abstract][Full Text] [Related]
17. MR cholangiopancreatography in patients with primary sclerosing cholangitis: interobserver variability and comparison with endoscopic retrograde cholangiopancreatography.
Vitellas KM; El-Dieb A; Vaswani KK; Bennett WF; Tzalonikou M; Mabee C; Kirkpatrick R; Bova JG
AJR Am J Roentgenol; 2002 Aug; 179(2):399-407. PubMed ID: 12130441
[TBL] [Abstract][Full Text] [Related]
18. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.
Cazzagon N; El Mouhadi S; Vanderbecq Q; Ferreira C; Finnegan S; Lemoinne S; Corpechot C; Chazouillères O; Arrivé L
JHEP Rep; 2022 Nov; 4(11):100577. PubMed ID: 36277957
[TBL] [Abstract][Full Text] [Related]
19. Impact on follow-up strategies in patients with primary sclerosing cholangitis.
Bergquist A; Weismüller TJ; Levy C; Rupp C; Joshi D; Nayagam JS; Montano-Loza AJ; Lytvyak E; Wunsch E; Milkiewicz P; Zenouzi R; Schramm C; Cazzagon N; Floreani A; Liby IF; Wiestler M; Wedemeyer H; Zhou T; Strassburg CP; Rigopoulou E; Dalekos G; Narasimman M; Verhelst X; Degroote H; Vesterhus M; Kremer AE; Bündgens B; Rorsman F; Nilsson E; Jørgensen KK; von Seth E; Cornillet Jeannin M; Nyhlin N; Martin H; Kechagias S; Wiencke K; Werner M; Beretta-Piccoli BT; Marzioni M; Isoniemi H; Arola J; Wefer A; Söderling J; Färkkilä M; Lenzen H;
Liver Int; 2023 Jan; 43(1):127-138. PubMed ID: 35535655
[TBL] [Abstract][Full Text] [Related]
20. Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis.
Petrovic BD; Nikolaidis P; Hammond NA; Martin JA; Petrovic PV; Desai PM; Miller FH
Dig Dis Sci; 2007 Dec; 52(12):3499-506. PubMed ID: 17410447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
